last week i read article november update leuprorelin trial caught attention following drug candidate leuprorelin pictured shown safe humans could help treat debilitating disease known spinal bulbar muscular atrophy i saw following comment although researchers found statistically significant difference swallowing function experimental control groups observed leuprorelin could effective patients disease less ten years past articles leuprorelin i read observations might prove interesting recently seen onset kennedy disease trial patients hospitals japan involved month trial leuprorelin placebo injected patients every twelve weeks could effective words stood me tempered excitement i might initially felt later reference second trial focused three swallowing tests made me wonder report initial trial results date back i read actual published report grabbed following comments mean difference pharyngeal barium residue piecemeal deglutition week significant difference groups covariate adjustment baseline data predefined subgroup analysis leuprorelin treatment associated greater reduction barium residue initial swallowing placebo patients disease duration less years interpretation weeks treatment leuprorelin show significant effects swallowing function patients spinal bulbar muscular atrophy although well tolerated disease duration might influence efficacy leuprorelin thus clinical trials sensitive outcome measures done subpopulations patients appears measure used determining benefit swallowing i read anything else used i walking standing stairs cramping strength tests etc looking back progression i remember swallowing problems first ten years onset course i could rare bird term neurologist uses introducing me students i aware least one man kennedy disease using leuprorelin united states i hope reads article determinations continuing